Renaissance Technologies (RenTech)'s TECH Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 12,900 shares of Bio-Techne Corporation (TECH) worth $934,863, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in TECH, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 710,080 shares. Largest reduction occurred in Q1 2015, reducing 982,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +12,900 | New Buy | 12,900 | $72.47 |
| Q3 2025 | -590,700 | Sold Out | 0 | $0.00 |
| Q2 2025 | +446,300 | Add 309.07% | 590,700 | $51.45 |
| Q1 2025 | +144,400 | New Buy | 144,400 | $58.63 |
| Q4 2023 | -258,326 | Sold Out | 0 | $0.00 |
| Q3 2023 | +178,526 | Add 223.72% | 258,326 | $68.07 |
| Q2 2023 | -379,900 | Reduce 82.64% | 79,800 | $0.08 |
| Q1 2023 | +41,300 | Add 9.87% | 459,700 | $0.07 |
| Q4 2022 | -665,376 | Reduce 61.39% | 418,400 | $0.08 |
| Q3 2022 | +498,976 | Add 85.32% | 1.08 M | $71.00 |
| Q2 2022 | +455,600 | Add 352.63% | 584,800 | $86.66 |
| Q1 2022 | +92,400 | Add 251.09% | 129,200 | $108.26 |
| Q4 2021 | +26,000 | Add 240.74% | 36,800 | $129.35 |
| Q3 2021 | -23,600 | Reduce 68.60% | 10,800 | $121.11 |
| Q2 2021 | -108,208 | Reduce 75.88% | 34,400 | $112.56 |
| Q1 2021 | -513,244 | Reduce 78.26% | 142,608 | $95.49 |
| Q4 2020 | -598,048 | Reduce 47.70% | 655,852 | $79.39 |
| Q3 2020 | -306,800 | Reduce 19.66% | 1.25 M | $61.93 |
| Q2 2020 | -386,580 | Reduce 19.85% | 1.56 M | $66.02 |
| Q1 2020 | -77,324 | Reduce 3.82% | 1.95 M | $47.41 |
| Q4 2019 | -243,876 | Reduce 10.75% | 2.02 M | $54.88 |
| Q3 2019 | +379,200 | Add 20.07% | 2.27 M | $48.92 |
| Q2 2019 | -72,000 | Reduce 3.67% | 1.89 M | $52.12 |
| Q1 2019 | -523,600 | Reduce 21.07% | 1.96 M | $49.64 |
| Q4 2018 | +710,080 | Add 40.01% | 2.48 M | $36.18 |
| Q3 2018 | +119,600 | Add 7.23% | 1.77 M | $51.03 |
| Q2 2018 | +174,000 | Add 11.75% | 1.66 M | $36.99 |
| Q1 2018 | +57,200 | Add 4.02% | 1.48 M | $37.76 |
| Q4 2017 | +445,200 | Add 45.48% | 1.42 M | $32.39 |
| Q3 2017 | +390,400 | Add 66.35% | 978,800 | $30.22 |
| Q2 2017 | -166,000 | Reduce 22.00% | 588,400 | $29.37 |
| Q1 2017 | +28,400 | Add 3.91% | 754,400 | $25.41 |
| Q4 2016 | +152,000 | Add 26.48% | 726,000 | $25.71 |
| Q3 2016 | +414,800 | Add 260.55% | 574,000 | $27.37 |
| Q2 2016 | -257,200 | Reduce 61.77% | 159,200 | $28.19 |
| Q1 2016 | -222,800 | Reduce 34.86% | 416,400 | $23.63 |
| Q4 2015 | -342,400 | Reduce 34.88% | 639,200 | $22.50 |
| Q3 2015 | +200,000 | Add 25.59% | 981,600 | $23.12 |
| Q2 2015 | -342,800 | Reduce 30.49% | 781,600 | $24.62 |
| Q1 2015 | -982,400 | Reduce 46.63% | 1.12 M | $25.07 |
| Q4 2014 | +2.11 M | New Buy | 2.11 M | $23.10 |
Renaissance Technologies (RenTech)'s Bio-Techne Corporation Investment FAQs
Renaissance Technologies (RenTech) first purchased Bio-Techne Corporation (TECH) in Q4 2014, acquiring 2,106,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Bio-Techne Corporation (TECH) for 41 quarters since Q4 2014.
Renaissance Technologies (RenTech)'s largest addition to Bio-Techne Corporation (TECH) was in Q4 2014, adding 2,106,800 shares worth $48.67 M.
According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 12,900 shares of Bio-Techne Corporation (TECH), valued at approximately $934,863.
As of the Q3 2026 filing, Bio-Techne Corporation (TECH) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Bio-Techne Corporation (TECH) was 2,484,880 shares, as reported at the end of Q4 2018.